These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 17532271)

  • 21. Early aggressive eradication therapy for intermittent Pseudomonas aeruginosa airway colonization in cystic fibrosis patients: 15 years experience.
    Hansen CR; Pressler T; Høiby N
    J Cyst Fibros; 2008 Nov; 7(6):523-30. PubMed ID: 18693078
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diagnostic significance of measurements of specific IgG antibodies to Pseudomonas aeruginosa by three different serological methods.
    Pressler T; Karpati F; Granström M; Knudsen PK; Lindblad A; Hjelte L; Olesen HV; Meyer P; Høiby N;
    J Cyst Fibros; 2009 Jan; 8(1):37-42. PubMed ID: 18835753
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prospective surveillance for Pseudomonas aeruginosa cross-infection at a cystic fibrosis center.
    Jones AM; Dodd ME; Govan JR; Doherty CJ; Smith CM; Isalska BJ; Webb AK
    Am J Respir Crit Care Med; 2005 Feb; 171(3):257-60. PubMed ID: 15542795
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antibody response to Pseudomonas aeruginosa in children with cystic fibrosis.
    Milagres LG; Castro TL; Garcia D; Cruz AC; Higa L; Folescu T; Marques EA
    Pediatr Pulmonol; 2009 Apr; 44(4):392-401. PubMed ID: 19283764
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Towards zero prevalence of chronic Pseudomonas aeruginosa infection in children with cystic fibrosis.
    Lebecque P; Leal T; Zylberberg K; Reychler G; Bossuyt X; Godding V
    J Cyst Fibros; 2006 Dec; 5(4):237-44. PubMed ID: 16790367
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neonatal screening for cystic fibrosis does not affect time to first infection with Pseudomonas aeruginosa.
    Baussano I; Tardivo I; Bellezza-Fontana R; Forneris MP; Lezo A; Anfossi L; Castello M; Aleksandar V; Bignamini E
    Pediatrics; 2006 Sep; 118(3):888-95. PubMed ID: 16950978
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Environmental contamination with an epidemic strain of Pseudomonas aeruginosa in a Liverpool cystic fibrosis centre, and study of its survival on dry surfaces.
    Panagea S; Winstanley C; Walshaw MJ; Ledson MJ; Hart CA
    J Hosp Infect; 2005 Feb; 59(2):102-7. PubMed ID: 15620443
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk factors for initial acquisition of Pseudomonas aeruginosa in children with cystic fibrosis identified by newborn screening.
    Maselli JH; Sontag MK; Norris JM; MacKenzie T; Wagener JS; Accurso FJ
    Pediatr Pulmonol; 2003 Apr; 35(4):257-62. PubMed ID: 12629621
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nosocomial cross-transmission of Pseudomonas aeruginosa between patients in a tertiary intensive care unit.
    Mayank D; Anshuman M; Singh RK; Afzal A; Baronia AK; Prasad KN
    Indian J Pathol Microbiol; 2009; 52(4):509-13. PubMed ID: 19805958
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nosocomial acquisition of Pseudomonas aeruginosa by cystic fibrosis patients.
    Tümmler B; Koopmann U; Grothues D; Weissbrodt H; Steinkamp G; von der Hardt H
    J Clin Microbiol; 1991 Jun; 29(6):1265-7. PubMed ID: 1907611
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differences in prevalence and treatment of Pseudomonas aeruginosa in cystic fibrosis centres in Denmark, Norway and Sweden.
    Knudsen PK; Olesen HV; Høiby N; Johannesson M; Karpati F; Laerum BN; Meyer P; Pressler T; Lindblad A;
    J Cyst Fibros; 2009 Mar; 8(2):135-42. PubMed ID: 19157995
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical impact of reducing routine susceptibility testing in chronic Pseudomonas aeruginosa infections in cystic fibrosis.
    Etherington C; Hall M; Conway S; Peckham D; Denton M
    J Antimicrob Chemother; 2008 Feb; 61(2):425-7. PubMed ID: 18156280
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Variable antibiotic susceptibility in populations of Pseudomonas aeruginosa infecting patients with bronchiectasis.
    Gillham MI; Sundaram S; Laughton CR; Haworth CS; Bilton D; Foweraker JE
    J Antimicrob Chemother; 2009 Apr; 63(4):728-32. PubMed ID: 19193658
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pseudomonas aeruginosa genotype prevalence in Dutch cystic fibrosis patients and age dependency of colonization by various P. aeruginosa sequence types.
    van Mansfeld R; Willems R; Brimicombe R; Heijerman H; van Berkhout FT; Wolfs T; van der Ent C; Bonten M
    J Clin Microbiol; 2009 Dec; 47(12):4096-101. PubMed ID: 19828746
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cross-infection with Pseudomonas aeruginosa among patients with cystic fibrosis.
    Agarwal G; Kapil A; Kabra SK; Das BK
    Natl Med J India; 2006; 19(4):236-7. PubMed ID: 17103494
    [No Abstract]   [Full Text] [Related]  

  • 36. Spread of an epidemic Pseudomonas aeruginosa strain from a patient with cystic fibrosis (CF) to non-CF relatives.
    McCallum SJ; Gallagher MJ; Corkill JE; Hart CA; Ledson MJ; Walshaw MJ
    Thorax; 2002 Jun; 57(6):559-60. PubMed ID: 12037234
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dynamics of adaptive microevolution of hypermutable Pseudomonas aeruginosa during chronic pulmonary infection in patients with cystic fibrosis.
    Hoboth C; Hoffmann R; Eichner A; Henke C; Schmoldt S; Imhof A; Heesemann J; Hogardt M
    J Infect Dis; 2009 Jul; 200(1):118-30. PubMed ID: 19459782
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bacterial contamination in the environment of hospitalised children with cystic fibrosis.
    Ferroni A; Werkhauser-Bertrand A; Le Bourgeois M; Beauvais R; Vrielynck S; Durand C; Lenoir G; Berche P; Sermet-Gaudelus I
    J Cyst Fibros; 2008 Nov; 7(6):477-82. PubMed ID: 18550452
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Survey of Pseudomonas aeruginosa genotypes in colonised cystic fibrosis patients.
    Van Daele S; Vaneechoutte M; De Boeck K; Knoop C; Malfroot A; Lebecque P; Leclercq-Foucart J; Van Schil L; Desager K; De Baets F
    Eur Respir J; 2006 Oct; 28(4):740-7. PubMed ID: 16774955
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phenotypic variability of Pseudomonas aeruginosa in sputa from patients with acute infective exacerbation of cystic fibrosis and its impact on the validity of antimicrobial susceptibility testing.
    Foweraker JE; Laughton CR; Brown DF; Bilton D
    J Antimicrob Chemother; 2005 Jun; 55(6):921-7. PubMed ID: 15883175
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.